Chapman Capital's Robert Chapman owns shares of Herbalife, and explains why he is interested in buying more stock, despite news the FTC opened an investigation into the company.
CNBC's Kate Kelly reports some of the biggest players in money management hold long positions in Herbalife as a personal bet against Bill Ackman.
CNBC's Scott Wapner and Herb Greenberg analyze Herbalife's stock price after the FTC investigation was announced.
Herbalife "welcomes" the FTC investigation. Herb Greenberg says this is "long overdue."
CNBC's Bob Pisani reports Herbalife has reopened for trading after halting on reports of an FTC investigation on the company.
The Financial Times is now reporting the FTC has opened a formal investigation into Herbalife, reports CNBC's Scott Wapner.
Activist investor Bill Ackman is hosting a conference call about Herbalife's China business. CNBC's Herb Greenberg weighs in.
Harvey Pitt, Kalorama Partners CEO & former SEC chairman, weighs in on the feud between Carl Icahn and Bill Ackman over Herbalife. "It's starting to look like Ackman is trying to get the stock price lower than it is currently trading at," Pitt says.
CNBC's Eamon Javers reports activist investor Bill Ackman will host a conference call today about Herbalife's China business.
CNBC's Eamon Javers reports Herbalife has responded to investor Bill Ackman's most recent attack.